Charles Elliott Sigal

Insider Reports History

Location
32 Brearly Road, Princeton, NJ
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Charles Elliott Sigal:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 2K $466K $232.95 May 8, 2025 by Trust
Vir Biotechnology, Inc. Director Common Stock 31.8K $196K $6.15 May 30, 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Common Stock 775 $181K $232.95 May 8, 2025 Direct
Vir Biotechnology, Inc. Director Common Stock 10K $61.5K $6.15 May 30, 2025 By Sigal Family Investments, LLC
Vir Biotechnology, Inc. Director Stock Option (Right to Buy) 16K $24.5K $1.53 May 30, 2025 Direct
Adaptimmune Therapeutics PLC Director Option to purchase Ordinary Shares 933K Jul 3, 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. Director Stock Option (right to buy) 1.56K May 8, 2025 Direct
Surface Oncology, Inc. Director Common Stock 0 $0.94 Sep 8, 2023 Indirect
Surface Oncology, Inc. Director Stock Option (Right to Buy) 0 Sep 8, 2023 Direct

Insider Reports Filed by Charles Elliott Sigal

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIR Vir Biotechnology, Inc. May 30, 2025 2 $0 4 Jun 2, 2025 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 8, 2025 2 $0 4 May 12, 2025 Director
VIR Vir Biotechnology, Inc. May 30, 2024 2 $0 4 Jun 3, 2024 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 16, 2024 1 $0 4 May 20, 2024 Director
SURF Surface Oncology, Inc. Sep 8, 2023 2 $0 4 Sep 8, 2023 Director
ADAP Adaptimmune Therapeutics PLC Jul 3, 2023 1 $0 4 Jul 3, 2023 Director
VIR Vir Biotechnology, Inc. May 22, 2023 2 $0 4 May 24, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. May 18, 2023 1 $0 4 May 19, 2023 Director
VIR Vir Biotechnology, Inc. Mar 1, 2023 1 $56.8K 4 Mar 2, 2023 Director
VIR Vir Biotechnology, Inc. Jan 5, 2023 1 $62.4K 4 Jan 9, 2023 Director
VIR Vir Biotechnology, Inc. Jan 3, 2023 2 $127K 4 Jan 5, 2023 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 22, 2022 1 $0 4 Aug 24, 2022 Director
ALNY ALNYLAM PHARMACEUTICALS, INC. Aug 22, 2022 0 $0 3 Aug 24, 2022 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2022 1 $0 4 Jul 1, 2022 Director
SURF Surface Oncology, Inc. Jun 8, 2022 1 $0 4 Jun 10, 2022 Director
VIR Vir Biotechnology, Inc. May 23, 2022 2 $0 4 May 25, 2022 Director
ADAP Adaptimmune Therapeutics PLC Jul 1, 2021 1 $0 4 Jul 2, 2021 Director
SURF Surface Oncology, Inc. Jun 8, 2021 1 $0 4 Jun 10, 2021 Director
VIR Vir Biotechnology, Inc. May 21, 2021 2 $0 4 May 25, 2021 Director